♫musicjinni

Inside the One Drop - Bayer Collaboration: New Cardiovascular Disease Product Is Just the Beginning

video thumbnail
Bayer’s $98M co-development-plus-investment in One Drop from August 2020 has yielded its first new product: a highly-personalized, AI-powered digital program aimed at preventing cardiovascular disease. While the solution itself is impressive in terms of its predictive analytics and integration into One Drop’s chronic condition precision health platform, what’s really remarkable about this milestone is that it demonstrates what’s possible when a pharma co and health tech startup are truly aligned as businesses, from R&D to go-to-market.

Bayer Pharmaceuticals’ CIO and Head of Digital & Commercial Innovation Jeanne Kehren and One Drop’s CEO Jeff Dachis take us inside their collaboration, with a very candid conversation about how their two orgs have not only developed a new product here today, but how they’ve established a solid foundation for a working relationship that’s poised to revolutionize chronic care and define a new market around precision health.

We talk strategy: for Bayer-One Drop... for what the “digital disruption” will bring to pharma... and for “putting a lab on everybody’s arm” via One Drop’s sensor that’s under development. This chat reveals how the thinking behind incumbent-disruptor partnerships has truly evolved, and what it will mean for bringing digital technologies into healthcare in a big and meaningful way. For me, hearing Jeanne say, “it all starts with pharma being ‘self-aware’” and that they need to “we stop slicing things into therapeutic areas and consider the individual” AND recognize that “not everything is going to be process-oriented and shaped like we do for drugs” is a sea-change from what we were hearing only a few years ago from pharma execs about partnering with health tech companies. Things are changing! Tune in to hear so much more.

***
Jessica DaMassa, the emerging ‘It girl’ of health tech interviewing, chats it up with the ‘who’s who’ of the health tech and healthcare innovation set on 'WTF Health - What's the Future, Health?' Catch 100's of interviews with leading health tech startups and the VC investors, health insurance companies, big pharma co's, and hospital systems helping bring their new ideas into the healthcare establishment. From AI and Big Data to digital health, virtual care, telehealth, digital therapeutics, payment model innovation, and investing, Jessica helps you spot the trends and figure out what’s next.

Subscribe to WTF Health’s YouTube Channel: https://www.youtube.com/wtfhealth
Follow Jess DaMassa on Twitter: https://twitter.com/jessdamassa
Visit WTF Health: https://www.wtf.health

"WTF Health - What's the Future, Health?" is sponsored in part by OneDrop, Transcarent, Signify Health, 120/80 MKTG, Bayer G4A, & Big Health.

Special thanks to our distribution partner, The Health Care Blog.

To learn more about WTF Health or throw some sponsorship dollars at our show yourself, check out www.wtf.health.

Inside the One Drop - Bayer Collaboration: New Cardiovascular Disease Product Is Just the Beginning

Disclaimer DMCA